核细胞死亡途径和前凝性血小板形成的融合分子机制
Cong Li1, Attila Braun2, Juan Zu3
1Division of Nephrology, Department of Medicine IV, Ludwig Maximilian University Hospital, 80336 Munich, Germany.
Cells
|July 25, 2025
概括
血液凝固至关重要的血小板与细胞死亡途径共享机制,但缺乏DNA碎片化. 了解这些过程有助于开发用于血栓形成和血栓细胞衰减的疗法.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 血栓凝固剂血小板对酸胺 (PS) 进行外部化,促进血栓生成和血栓形成.
- 血小板激活与核细胞死亡途径具有共同的特征,例如线粒体功能障碍和过载.
- 与核细胞不同,血小板缺乏核和依赖酶的DNA碎片化.
研究的目的:
- 将血小板形成的前凝剂与核细胞死亡途径 (死,死,热,铁) 进行比较.
- 探索这些途径在病理性血栓形成和血液凝固中的作用.
- 确定异常的血液凝固和血小板缺血的潜在治疗点.
主要方法:
- 对促凝血剂血小板形成和核细胞死亡中的分子机制的比较分析.
- 对有关血小板激活,细胞死亡途径和血栓形成的现有文献的综述.
- 探索共享和不同的分子事件的功能后果.
主要成果:
- 血小板形成涉及PS外部化和复杂组合,但不涉及DNA碎片化.
- 共享的途径可以增强血栓的形成,而不会减少血小板的寿命.
- 过度的血小板激活会导致溶解,模仿细胞的完全死亡,并导致血小板缺血.
结论:
- 了解益血凝剂血小板激活和细胞死亡途径之间的相互作用是关键.
- 针对这些机制可能为血栓性疾病提供新的治疗策略.
- 进一步的研究可以阐明预防病态凝血,血小板死亡和血小板减少的途径.
相关概念视频
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911


